Skip to main content

Advertisement

EHMTI-0297. Influences of psychiatric and behaviral factors on treatment effects in the school-age children with migraine

Article metrics

  • 414 Accesses

Purpose

School-aged children with severe migraine might need medication, and often accompanied by a psychiatric or behavioral problems. Thus, study for the effect of its problems on treatment of severe pediatric migraine is very important.

Materials and methods

Among the 197 school-aged children who were diagnosed as migraine by ICHD-3b, seventy-two patients who need prophylactic therapy were enrolled from January 2012 to December 2013. Secondary headaches and headaches with ADHD or require psychiatric treatments were excluded. Before treatment, all patients were checked by Childhood behavioral checklist (CBCL), Children's Anxiety Scale (CAS) and Children's Depression Inventory (CDI) for screening of behavioral and psychological problems, and administered with topiramate (25-50 mg hs) as a prophylactic medication. They were followed-up at intervals of 2-4 weeks and grouped as good responder (GR) and poor responder (PR).

Results

A total of 72 patients was M:F; 28:44, mean-age; 11.2±2.7 years. GR (45 patients; 62.5%, M:F;18:27, age; 10.7±2.5) and PR (27; 34.7%, M:F; 10:17, age; 12.0±3.0) were no statistically different. Features of headache in GR (duration; about 6 mo, attack duration; 9 h, frequencies; 12/mo) and PR (duration; about 12 mo, attack duration; 4 h, frequencies; 16/mo) had no significant difference. T-scores of GR and PR group were statistically different in total behavior problems, internalizing problems, depression/anxiety, social immaturity, attention problems of CBCL (p<0.01), but not different in factors of depression or anxiety in CAS and CDI.

Conclusion

Because behavioral factors affect the treatment children with migraine, it is important to selection of drugs or management of behavioral problems.

No conflict of interest.

Author information

Correspondence to K Lee.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Keywords

  • Migraine
  • Behavioral Problem
  • Topiramate
  • Poor Responder
  • Prophylactic Therapy

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.